Mark A Sirgo - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark A Sirgo. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Mark A Sirgo has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark A Sirgo. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BMRA / Biomerica, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BMRA / Biomerica, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2016-08-03	BMRA	Sirgo Mark A	4,000	2.0500	500	16.4000	8,200	23	3.192	-6,604	-80.54
2016-08-02	BMRA	Sirgo Mark A	1,850	2.0000	231	16.0000	3,700
2016-08-02	BMRA	Sirgo Mark A	2,150	2.0100	269	16.0800	4,322
2016-08-01	BMRA	Sirgo Mark A	2,000	1.9000	250	15.2000	3,800
2016-08-01	BMRA	Sirgo Mark A	175	1.9800	22	15.8400	346
2016-08-01	BMRA	Sirgo Mark A	1,825	1.9600	228	15.6800	3,577

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales BMRA / Biomerica, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BMRA / Biomerica, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2020-04-21	BMRA	Sirgo Mark A	5,000	8.1063	625	64.8504	40,532	364	4.28	-37,856	-93.40
2020-04-17	BMRA	Sirgo Mark A	68	8.0900	8	64.7200	550
2020-04-17	BMRA	Sirgo Mark A	100	8.0600	12	64.4800	806
2020-04-17	BMRA	Sirgo Mark A	1,076	8.0500	134	64.4000	8,662
2020-04-17	BMRA	Sirgo Mark A	1,302	8.0700	163	64.5600	10,507
2020-04-17	BMRA	Sirgo Mark A	2,454	8.0770	307	64.6160	19,821

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases NMTRQ / 9 Meters Biopharma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BMRA / Biomerica, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2022-07-01	NMTR	Sirgo Mark A	175,000	0.2455	8,750	4.9100	42,962	55	6.3	12,163	28.31
2022-05-18	NMTR	Sirgo Mark A	106,383	0.4700	5,319	9.4000	50,000
2022-03-03	NMTR	Sirgo Mark A	86,450	0.5784	4,322	11.5680	50,002
2021-12-02	NMTR	Sirgo Mark A	50,000	0.8900	2,500	17.8000	44,500
2021-11-18	NMTR	Sirgo Mark A	20,000	1.0600	1,000	21.2000	21,200
2021-09-07	NMTR	Sirgo Mark A	73,529	1.3600	3,676	27.2000	99,999
2021-08-20	NMTR	Sirgo Mark A	25,000	1.1000	1,250	22.0000	27,500
2021-04-05	NMTR	Sirgo Mark A	300,000	1.0000	15,000	20.0000	300,000
2020-12-15	NMTR	Sirgo Mark A	230,769	0.6500	11,538	13.0000	150,000
2020-09-11	NMTR	Sirgo Mark A	77,000	0.6800	3,850	13.6000	52,360
2020-09-11	NMTR	Sirgo Mark A	21,485	0.6518	1,074	13.0360	14,004
2020-09-10	NMTR	Sirgo Mark A	50,000	0.6000	2,500	12.0000	30,000
2020-08-17	NMTR	Sirgo Mark A	100,000	0.5600	5,000	11.2000	56,000
2020-06-15	NMTR	Sirgo Mark A	17,943	0.5975	897	11.9500	10,721

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales NMTRQ / 9 Meters Biopharma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BMRA / Biomerica, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Mark A Sirgo as disclosed to the Securities Exchange Commission (SEC).